News2018-10-25T23:58:32+00:00

Latest News

The Phage Futures Congress 2019

JAFRAL is going to attend The Phage Futures 2019 in Washington, US. You are welcome to meet with our representative at the conference dr. Frenk Smrekar [...]

Gene therapy IL-12 clinical trial

JAFRAL is proud to be a GMP manufacturing partner of a consortium/project for first clinical trial on combined electrochemotherapy with gene therapy with Interleukin-12 (IL-12) to improve/enhance local and systemic response to skin tumor treatment.

Competence Center Bio-Pharm

As of June 1 2018 JAFRAL is a part of Bio-Pharm Competence Center for Biotechnology and Pharmaceuticals.

Phage Therapy & Antibiotic Resistance 2018

JAFRAL is going to attend and held presentation at Phage Therapy & Antibiotic Resistance 2018 in Florence, Italy. You are welcome to meet with our representative at the conference dr. Frenk Smrekar

Load More Posts